×
Amphastar Pharmaceuticals Net Profit Margin 2012-2024 | AMPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Amphastar Pharmaceuticals net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Amphastar Pharmaceuticals Net Profit Margin 2012-2024 | AMPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Amphastar Pharmaceuticals net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.9B
BridgeBio Pharma (BBIO)
$4.4B
Bausch Health Cos (BHC)
$2.9B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$506M
Personalis (PSNL)
$245M
Assembly Biosciences (ASMB)
$96M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M